BridgeBio Pharma (BBIO) Cash from Operations (QoQ) (2018 - 2026)
BridgeBio Pharma (BBIO) Cash from Operations (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -249.66% |
| Dec 31, 2025 | 48.51% |
| Sep 30, 2025 | -35.81% |
| Jun 30, 2025 | 59.50% |
| Mar 31, 2025 | -2.00% |
| Dec 31, 2024 | -8.17% |
| Sep 30, 2024 | -341.71% |
| Jun 30, 2024 | 134.03% |
| Mar 31, 2024 | -75.88% |
| Dec 31, 2023 | 14.05% |
| Sep 30, 2023 | -28.12% |
| Jun 30, 2023 | 21.46% |
| Mar 31, 2023 | -54.78% |
| Dec 31, 2022 | 31.01% |
| Sep 30, 2022 | -343.84% |
| Jun 30, 2022 | 81.04% |
| Mar 31, 2022 | -19.97% |
| Dec 31, 2021 | -10.15% |
| Sep 30, 2021 | -32.55% |
| Jun 30, 2021 | 39.17% |